The global bone mineral densitometry (BMD) market is on a trajectory of growth, projected to reach a value of US$ 495.1 million by 2034, according to Fact.MR. This upward trend is fueled by the growing recognition of the importance of bone density assessment for diagnosing osteoporosis and gauging fracture risk.
The aging global population, particularly postmenopausal women who are at higher risk of osteoporosis and fractures, is a key driver of market growth. BMD devices are increasingly becoming vital tools in various medical fields, including sports medicine, pediatrics, and even space exploration. Their non-invasive nature and minimal radiation exposure make them ideal for widespread screening initiatives.
Furthermore, densitometers are increasingly being utilized in fields like fitness and nutrition due to their ability to assess body composition. As awareness of bone health continues to rise and new applications for densitometry emerge, the BMD market is poised for continued expansion.
Key Highlights of the Market Study:
* The global bone mineral densitometry market is expected to reach a size of US$ 495.1 million by the end of 2034.
* East Asia is anticipated to account for 5% of the global market by 2034.
* The North American market is forecasted to reach a valuation of US$ 184 million by 2034.
* Sales of DXA devices are estimated at US$ 225.9 million in 2024.
* The hospitals segment is expected to account for a market share of 5% in 2024.
Innovation Driving the Market:
Leading players in the BMD market, including GE Healthcare, Hologic Inc., DMS Imaging, and Swissray International Inc., are actively driving innovation in the field. The focus is on enhancing clinical efficiency and patient comfort through advancements in technology, such as 3D imaging capabilities and portable devices. These innovations aim to provide a more comprehensive view of bone quality and structure, expand access to screening, and streamline workflows.
Emerging technologies like radiofrequency echographic multi-spectrometry (REMS) are offering radiation-free alternatives to traditional DXA scans. Furthermore, algorithmic advancements are creating opportunities for opportunistic bone health screening through routine CT scans.
The Future of BMD:
The BMD market is expected to continue its growth trajectory, driven by factors such as the increasing prevalence of osteoporosis and bone-related disorders, the expanding applications of densitometers, and advancements in technology. The focus on enhancing patient comfort and accessibility to screening will play a significant role in shaping the future of the BMD market.
